Effect of sulfate Magnesium and Dexmedetomidine in ?duration of sensory and motor block in Axillary block

Comparison of added Sulfate Magnesium and Dexmedetomidine for prolongation of the ?duration of sensory and motor block in axillary block

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017041920258N38

Enrollment

Registered

2017-06-21

Start date

2017-03-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: fracture in forearm. Condition 2: fracture in hand. Fracture of forearm Fracture at wrist and hand level

Interventions

Intervention 1: Intervention group 1:We will inject 0.5 micro gram in kilogram of Dexmedetomidine and Lidocaine 1.5 ?percent in first group . Intervention 2: Intervention group 2: We will inject 100

Treatment - Drugs

Intervention group 1:We will inject 0.5 micro gram in kilogram of Dexmedetomidine and Lidocaine 1.5 ?percent in first group .

Intervention group 2: We will inject 100 milligram of Sulfate Magnesium and ?Lidocaine 1.5 percent in second group.

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ASA class I and II; 18 to 60 years; patients ?candidate forearm and hand ?surgery with Axillary block; fracture in forearm and hand; lack of coagulation ?disorders; lack of psychological problems; don't pregnant women ;don't history of allergy to ?drugs; lack of chronic pain syndrome; lack of neurological disorders in hands; body mass index less than 35 Exclusion criteria: more than one fracture in body and more than one surgery; ?uncooperative patients for block; infection in area of ?block; failure in block; surgical time ?more than 120 minutes; sedation needed more than rates in study ??

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sensory block. Timepoint: every 1 minute. Method of measurement: Bromeg scale.;Motor block. Timepoint: every 5 minute. Method of measurement: Bromeg scale.;Heart rate. Timepoint: Every 15 minute to recovery. Method of measurement: count.;Mean arterial pressure. Timepoint: Every 15 minute to recovery. Method of measurement: Mercury sphygmomanometer.;Oxygen saturation. Timepoint: Every 15 minute to recovery. Method of measurement: pulse oximetry.;Pain. Timepoint: recovery and 4 hours after surgery. Method of measurement: Visual Analogue Scale Questionnaire.;Mean of narcotic. Timepoint: 24 hour after surgery. Method of measurement: miligeram.	—

Measure

Time frame

Sensory block. Timepoint: every 1 minute. Method of measurement: Bromeg scale.;Motor block. Timepoint: every 5 minute. Method of measurement: Bromeg scale.;Heart rate. Timepoint: Every 15 minute to recovery. Method of measurement: count.;Mean arterial pressure. Timepoint: Every 15 minute to recovery. Method of measurement: Mercury sphygmomanometer.;Oxygen saturation. Timepoint: Every 15 minute to recovery. Method of measurement: pulse oximetry.;Pain. Timepoint: recovery and 4 hours after surgery. Method of measurement: Visual Analogue Scale Questionnaire.;Mean of narcotic. Timepoint: 24 hour after surgery. Method of measurement: miligeram.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026